Sibylle J. Hauske

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function

Faı̈ez Zannad, João Pedro Ferreira, Stuart Pocock et al. · Circulation · 2020 · 262 citations · Full text

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Carnosine Attenuates the Development of both Type 2 Diabetes and Diabetic Nephropathy in BTBR ob/ob Mice

Thomas Albrecht, Maaike Schilperoort, Shiqi Zhang et al. · Scientific Reports · 2017 · 123 citations · Full text

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Adeera Levin, Rajiv Agarwal, William G. Herrington et al. · Kidney International · 2020 · 112 citations · Full text

The association between estimated glomerular filtration rate, albuminuria, and risk of cardiovascular hospitalizations and all-cause mortality among patients with type 2 diabetes

Gregory A. Nichols, Anouk Déruaz‐Luyet, Sibylle J. Hauske et al. · Journal of Diabetes and its Complications · 2017 · 42 citations

All-cause Mortality, Hemodialysis, Urology +13